Table 1.
Peptides | Start and end position | Sequence |
---|---|---|
PS1 |
1–30 aa |
MSVSLHHFIISSGFLASMFPKAVRRAVTAG |
PS2 |
31–60 aa |
VFAAPTLMSFLRCGAMASDPPLVANQVVTC |
PS3 |
61–90 aa |
PDKKSTAAVILTPTENHFTLKCPKTALTEP |
PS4 |
91–120 aa |
PTLAYSPNRQICPAGTTSSCTSKAVTLSSL |
PS5 |
121–150 aa |
IPEAEDSWWTGDSASLDTAGIKLTVPIEKF |
PS6 |
151–180 aa |
PVTTQTFVVGCIKGDDAQSCMVTVTVQARA |
PS7 |
181–210 aa |
SSVVNNVARCSYGANSTLGPVKLSAEGPTT |
PS8 |
211–240 aa |
MTLVCGKDGVKVPQDNNQYCSGTTLTGCNE |
PS9 |
241–270 aa |
KSFKDILPKLSENPWQGNASSDNGATLTIN |
PS10 |
271–300 aa |
KEAFPAESKSVIIGCTGGSPEKHHCTVQLE |
PS11 |
301–336 aa |
FAGAAGSAKSSAGTASHVSIFAMVTGLIGSIAACVA |
PS4-1 |
91–105 aa |
PTLAYSPNRQICPAG |
PS4-2 |
106–120 aa |
TTSSCTSKAVTLSSL |
PS4-3 |
100–114 aa |
QICPAGTTSSCTSKA |
PS6-1 |
151–165 aa |
PVTTQTFVVGCIKGD |
PS6-2 |
159–173 aa |
VGCIKGDDAQSCMVT |
PS6-3 |
166–180 aa |
DAQSCMVTVTVQARA |
PS10-1 |
271–305 aa |
KEAFPAESKSVIIGC |
PS10-2 |
281–294 aa |
VIIGCTGGSPEKHH |
PS10-3 |
289–300 aa |
SPEKHHCTVQLE |
PS11-1 |
301–315 aa |
FAGAAGSAKSSAGTA |
PS11-2 |
313–332 aa |
GTASHVSIFAMVTGLIGSIA |
PS11-3 | 306–320 aa | GSAKSSAGTASHVSI |